Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk A/S (UK) (DE:NOV)
:NOV
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 196.50B | $ 148.51B | $ 117.14B | $ 106.01B | $ 101.93B |
| Operating Income | $ 102.45B | $ 73.78B | $ 58.64B | $ 54.13B | $ 51.88B |
| EBITDA | - | - | $ 65.39B | - | - |
| Net Income | $ 83.68B | $ 55.05B | $ 47.76B | $ 41.99B | $ 38.95B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 314.49B | $ 241.26B | $ 194.51B | $ 144.92B | $ 125.61B |
| Total Debt | $ 27.01B | $ 50.10B | $ 26.64B | $ 10.36B | $ 4.48B |
| Net Debt | $ -3.22B | $ 26.53B | $ 9.16B | $ -2.40B | $ -10.99B |
| Total Liabilities | $ 377.58B | $ 278.71B | $ 123.76B | $ 81.60B | $ 68.02B |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ 70.01B | $ 64.13B | $ 47.62B | $ 29.88B | $ 35.55B |
| Operating Cash Flow | $ 108.91B | $ 78.89B | $ 55.00B | $ 51.95B | $ 46.78B |
| Investing Cash Flow | |||||
| Financing Cash Flow |